Sign in
Groups
Researchers
Results
AIDS AND HIV INFECTIONS
Lund University
Lund, Suecia
You are in
Collaborations
Lund University
Publications in collaboration with researchers from Lund University (2)
2019
Week 96 efficacy and safety results of the phase 3, randomized EMERALD trial to evaluate switching from boosted-protease inhibitors plus emtricitabine/tenofovir disoproxil fumarate regimens to the once daily, single-tablet regimen of darunavir/cobicistat/emtricitabine/tenofovir alafenamide (D/C/F/TAF) in treatment-experienced, virologically-suppressed adults living with HIV-1
Antiviral Research, Vol. 170
2015
Development and Validation of a Risk Score for Chronic Kidney Disease in HIV Infection Using Prospective Cohort Data from the D:A:D Study
PLoS Medicine, Vol. 12, Núm. 3
Contact
Legal notice
Help
translate
en
arrow_drop_down
translate
en
arrow_drop_down
es
eu
fr
de
